Professional Documents
Culture Documents
Retinal Degenerative Diseases Xix John Ash Full Chapter PDF
Retinal Degenerative Diseases Xix John Ash Full Chapter PDF
John Ash
Visit to download the full and correct content document:
https://ebookmass.com/product/retinal-degenerative-diseases-xix-john-ash/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://ebookmass.com/product/outspoken-raina-ash/
https://ebookmass.com/product/the-elemental-collective-montana-
ash/
https://ebookmass.com/product/stand-the-fieldings-
book-3-kimberley-ash/
https://ebookmass.com/product/volcanic-ash-hazard-
observation-1st-edition-shona-mackie/
Deathless (Vengeful Gods MC Book 3) Crystal Ash
https://ebookmass.com/product/deathless-vengeful-gods-mc-
book-3-crystal-ash/
https://ebookmass.com/product/ash-bratva-blood-brothers-
book-1-jax-knight/
https://ebookmass.com/product/human-diseases-neighbors/
https://ebookmass.com/product/atlas-of-retinal-oct-optical-
coherence-tomography-1st-edition-darin-goldman/
Retinal
Degenerative
Diseases XIX
Mechanisms and Experimental Therapy
Advances in Experimental Medicine
and Biology
Volume 1415
Series Editors
Wim E. Crusio, Institut de Neurosciences Cognitives et Intégratives
d’Aquitaine, CNRS and University of Bordeaux, Pessac Cedex, France
Haidong Dong, Departments of Urology and Immunology, Mayo Clinic
Rochester, MN, USA
Heinfried H. Radeke, Institute of Pharmacology and Toxicology, Clinic of
the Goethe University Frankfurt Main, Frankfurt am Main, Hessen,
Germany
Nima Rezaei, Research Center for Immunodeficiencies, Children’s Medical
Center, Tehran University of Medical Sciences, Tehran, Iran
Ortrud Steinlein, Institute of Human Genetics, LMU University Hospital
Munich, Germany
Junjie Xiao, Cardiac Regeneration and Ageing Lab, Institute of
Cardiovascular Sciences, School of Life Science, Shanghai University
Shanghai, China
Advances in Experimental Medicine and Biology provides a platform for
scientific contributions in the main disciplines of the biomedicine and the life
sciences. This series publishes thematic volumes on contemporary research in
the areas of microbiology, immunology, neurosciences, biochemistry,
biomedical engineering, genetics, physiology, and cancer research. Covering
emerging topics and techniques in basic and clinical science, it brings together
clinicians and researchers from various fields.
Advances in Experimental Medicine and Biology has been publishing
exceptional works in the field for over 40 years, and is indexed in SCOPUS,
Medline (PubMed), EMBASE, BIOSIS, Reaxys, EMBiology, the Chemical
Abstracts Service (CAS), and Pathway Studio.
2021 Impact Factor: 3.650 (no longer indexed in SCIE as of 2022)
John D. Ash • Eric Pierce
Robert E. Anderson
Catherine Bowes Rickman
Joe G. Hollyfield • Christian Grimm
Editors
Retinal Degenerative
Diseases XIX
Mechanisms and Experimental
Therapy
Editors
John D. Ash Eric Pierce
Department of Ophthalmology Ocular Genomics Institute
University of Pittsburgh School Department of Ophthalmology
of Medicine Massachusetts Eye and Ear Infirmary
Pittsburgh, PA, USA Harvard Medical School
Boston, MA, USA
Robert E. Anderson
Health Sciences Center Catherine Bowes Rickman
University of Oklahoma Health Department of Ophthalmology
Sciences Center Duke Medical Center
Oklahoma City, OK, USA Durham, NC, USA
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature
Switzerland AG 2023
This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher,
whether the whole or part of the material is concerned, specifically the rights of translation,
reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any
other physical way, and transmission or information storage and retrieval, electronic adaptation,
computer software, or by similar or dissimilar methodology now known or hereafter developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this
publication does not imply, even in the absence of a specific statement, that such names are
exempt from the relevant protective laws and regulations and therefore free for general use.
The publisher, the authors, and the editors are safe to assume that the advice and information in
this book are believed to be true and accurate at the date of publication. Neither the publisher nor
the authors or the editors give a warranty, expressed or implied, with respect to the material
contained herein or for any errors or omissions that may have been made. The publisher remains
neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This Springer imprint is published by the registered company Springer Nature Switzerland AG
The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
The editors are pleased dedicate this publication to the memory
of our long-time friend and colleague, Alan M. Laties. Except
for the most recent years, Alan attended each of these biennial
retinal degeneration meetings since they began in 1984. Early
on Alan recognized the importance of our attempt to provide a
continuing international platform for discussions and scientific
exchange to take place among investigators focused on retinal
degeneration research. Through his scientific leadership at the
Foundation Fighting Blindness (formerly the Retinitis
Pigmentosa Foundation), we received the first meeting grant to
partially cover some of the expenses of the RD meeting held in
San Francisco in 1988. The Foundation has provided
continuing support for each of the subsequent meetings in the
form of travel grant support for young investigators.
Born in Beverly, Massachusetts, the son of Russian immigrants,
he attended Harvard College (BA, 1954) and completed
medical school at Baylor College of Medicine (MD, 1959),
followed by a residency in ophthalmology in the Hospital of the
University of Pennsylvania (1961–63). A United States Public
Health Service Special Research Fellowship supported his
vi
ix
x Preface
xi
xii Contents
Part VI Inflammation
Part X Neuroprotection
Part XI Photoreceptors
Lysine Ubiquitylation Drives Rhodopsin Protein Turnover���������������� 493
Allen P. F. Chen, Leon Chea, Eun-Jin Lee,
and Jonathan H. Lin
Silico Prediction of MYO1C-Rhodopsin Interactions
In
and Its Significance in Protein Localization
and Visual Function �������������������������������������������������������������������������������� 499
Glenn P. Lobo, Rakesh Radhakrishnan, Matthias Leung,
Andrew Gruesen, Hans-Joachim Knölker, Frederik J. van Kuijk,
and Sandra R. Montezuma
A Ciliary Branched Actin Network Drives
Photoreceptor Disc Morphogenesis�������������������������������������������������������� 507
William J. Spencer and Vadim Y. Arshavsky
Part XII RPE
Revisiting the Daily Timing of POS Phagocytosis�������������������������������� 515
Antonio E. Paniagua, Harjas S. Sabharwal, Kausalya Kethu,
Andrew W. Chang, and David S. Williams
Inhibition of Bacterial Peptidoglycan Cytopathy
by Retina Pigment Epithelial PGRP2 Amidase������������������������������������ 521
Marlyn P. Langford, Laura A. Perilloux-Lyons,
and A. Scott Kavanaugh
Understanding Ischemic Retinopathies: The Role
of Succinate and Its Receptor in Retinal
Pigment Epithelium �������������������������������������������������������������������������������� 527
Bilge Esin Ozturk
The Amphipathic Helix in Visual Cycle Proteins: A Review���������������� 533
Sheetal Uppal, Eugenia Poliakov, Susan Gentleman,
and T. Michael Redmond
The Retinal Pigment Epithelium: Cells That Know the Beat!������������ 539
Elora M. Vanoni and Emeline F. Nandrot
Index�������������������������������������������������������������������������������������������������������� 583
Part I
Age-related Macular Degeneration
High-Resolution Imaging Mass
Spectrometry of Human Donor Eye:
Photoreceptors Cells and Basal
Laminar Deposit of Age-Related
Macular Degeneration
Fig. 1 MALDI IMS signals consistent with localization MALDI IMS images and H&E-stained tissue images
to photoreceptor and RPE compartments. (a) Schematic overlaid in perifoveal retina displaying signals from mul-
diagram of outer retina, excerpted from Fig. 1a. Blue, tiple lipid classes that localize to subcellular compart-
pink, yellow, and green bands indicate layers formed by ments of the photoreceptor cells. (b) Overlay showing
highly compartmentalized and vertically aligned photore- four separate signals. (c) Localized to ONL. (d) Localized
ceptors and RPE cells in panels b, c. Layers: OPL outer to photoreceptor inner and outer segments. (e) Localized
plexiform layer, ONL outer nuclear layer, ELM external to mitochondria-rich photoreceptor inner segments. (f)
limiting membrane, RPE retinal pigment epithelium, BrM Localized to RPE apical processes
Bruch’s membrane, R rod, C cone photoreceptors. (b–f)
6 D. M. G. Anderson et al.
Fig. 2 Imaging mass spectrometry (IMS) for molecularly pigmented debris (yellow) and dysmorphic RPE overly-
informed optical coherence tomography (OCT) and ing BLamD. Insert, BLamD with basal mound (arrow).
tissue-level target discovery. Asterisk, foveal pit; RPE, Basal mounds contain soft druse material. Layers: GCL
retinal pigment epithelium. Color-coded arrowheads rep- ganglion cell, INL inner nuclear, HFL Henle fiber, ONL
resent corresponding structures across modalities, in a outer nuclear. (c) Autofluorescent, pigmented debris (yel-
93-year-old human donor eye. (a) OCT B-scan shows low) and dysmorphic RPE (green). (d) IMS reveals an m/z
subretinal hyperreflective material (yellow) and an RPE signal at 799.673, restricted to BLamD and not detected in
elevation (green). (b) H&E stained cryosection shows the RPE
ease. Understanding molecular processes occur- 9. Chen Y, Jester JV, Anderson DM, Marchitti SA, Schey
KL, Thompson DC, et al. Corneal haze phenotype
ring in BLamD in early AMD is important as in Aldh3a1-null mice: in vivo confocal microscopy
they are early-identified histologic risk factors and tissue imaging mass spectrometry. Chem Biol
for AMD progression [18] and are just now being Interact. 2017;276:9–14.
recognized clinically [19, 20]. 10. Anderson DM, Ablonczy Z, Koutalos Y, Spraggins
J, Crouch RK, Caprioli RM, et al. High reso-
lution MALDI imaging mass spectrometry of
Acknowledgments This project was supported by the retinal tissue lipids. J Am Soc Mass Spectrom.
National Institutes of Health P41 GM103391 (R.M.C.) 2014;25(8):1394–403.
and R01 EY027948 (C.A.C.). Support was also received 11. Anderson DMG, Ablonczy Z, Koutalos Y,
by a Research to Prevent Blindness Catalyst Award for Hanneken AM, Spraggins JM, Calcutt MW, et al.
Innovative Research Approaches for Age-Related Macular Bis(monoacylglycero)phosphate lipids in the retinal
Degeneration to K.L.S. pigment epithelium implicate lysosomal/endosomal
dysfunction in a model of Stargardt disease and
human retinas. Sci Rep. 2017;7(1):17352.
12. Patterson NH, Tuck M, Van de Plas R, Caprioli
References RM. Advanced registration and analysis of
MALDI imaging mass spectrometry measurements
1. Caprioli RM, Farmer TB, Gile J. Molecular imag- through autofluorescence microscopy. Anal Chem.
ing of biological samples: localization of peptides 2018;90(21):12395–403.
and proteins using MALDI-TOF MS. Anal Chem. 13. Pang CE, Messinger JD, Zanzottera EC, Freund KB,
1997;69(23):4751–60. Curcio CA. The onion sign in neovascular age-related
2. Bowrey HE, Anderson DM, Pallitto P, Gutierrez DB, macular degeneration represents cholesterol crystals.
Fan J, Crouch RK, et al. Imaging mass spectrometry Ophthalmology. 2015;122(11):2316–26.
of the visual system: advancing the molecular under- 14. Hankin J, Barkley R, Murphy R. Sublimation as
standing of retina degenerations. Proteomics Clin a method of matrix application for mass spec-
Appl. 2016;10(4):391–402. trometric imaging. J Am Soc Mass Spectrom.
3. Anderson DMG, Messinger JD, Patterson NH, Rivera 2007;18(9):1646–52.
ES, Kotnala A, Spraggins JM, et al. Lipid landscape 15. Liu A, Chang J, Lin Y, Shen Z, Bernstein PS. Long-
of the human retina and supporting tissues revealed chain and very long-chain polyunsaturated fatty acids
by high resolution imaging mass spectrometry. bioR in ocular aging and age-related macular degeneration.
xiv:2020:2020.04.08.029538. J Lipid Res. 2011;51:3217–29.
4. Zemski Berry KA, Gordon WC, Murphy RC, Bazan 16. Curcio CA, Presley JB, Malek G, Medeiros NE,
NG. Spatial organization of lipids in the human retina Avery DV, Kruth HS. Esterified and unesteri-
and optic nerve by MALDI imaging mass spectrom- fied cholesterol in drusen and basal deposits of
etry. J Lipid Res. 2014;55(3):504–15. eyes with age-related maculopathy. Exp Eye Res.
5. Anderson DM, Spraggins JM, Rose KL, Schey 2005;81(6):731–41.
KL. High spatial resolution imaging mass spectrom- 17. Wang L, Li C-M, Rudolf M, Belyaeva OV, Chung
etry of human optic nerve lipids and proteins. J Am BH, Messinger JD, et al. Lipoprotein particles of
Soc Mass Spectrom. 2015;26(6):940–7. intraocular origin in human Bruch membrane: an
6. Stark DT, Anderson DMG, Kwong JMK, Patterson unusual lipid profile. Invest Ophthalmol Vis Sci.
NH, Schey KL, Caprioli RM, et al. Optic nerve regen- 2009;50(2):870–7.
eration after crush remodels the injury site: molecu- 18. Sarks SH. Ageing and degeneration in the macular
lar insights from imaging mass spectrometryoptic region: a clinico-pathological study. Br J Ophthalmol.
nerve regeneration imaging mass spectrometry. Invest 1976;60(5):324–41.
Ophthalmol Vis Sci. 2018;59(1):212–22. 19. Tan ACS, Astroz P, Dansingani KK, Slakter JS,
7. Grey AC, Schey KL. Age-related changes in the spa- Yannuzzi LA, Curcio CA, et al. The plateau, an
tial distribution of human lens alpha-crystallin prod- optical coherence tomographic signature of geo-
ucts by MALDI imaging mass spectrometry. Invest graphic atrophy: evolution, multimodal imaging,
Ophthalmol Vis Sci. 2009;50(9):4319–29. and candidate histology. Invest Ophthalmol Vis Sci.
8. Stella DR, Floyd KA, Grey AC, Renfrow MB, 2017;58(4):2349–58.
Schey KL, Barnes S. Tissue localization and solu- 20. Sura AA, Chen L, Messinger JD, Swain TA, McGwin
bilities of alphaA-crystallin and its numerous G Jr, Freund KB, et al. Measuring the contributions of
C-terminal truncation products in pre- and postcata- basal laminar deposit and Bruch’s membrane in age-
ractous ICR/f rat lenses. Invest Ophthalmol Vis Sci. related macular degeneration. Invest Ophthalmol Vis
2010;51(10):5153–61. Sci. 2020;61(13):19.
The Noncanonical Role
of Complement Factor H in Retinal
Pigment Epithelium (RPE) Cells
and Implications for Age-Related
Macular Degeneration (AMD)
the individual’s quality of life but also poses a 402H of FH causes uncontrolled complement
significant burden on healthcare systems world- activation in vitro and in vivo [9]. Moreover,
wide [3]. The early stages of the disease are char- complement factors accumulate in drusen [10],
acterized by the presence of enlarging drusen in and increased complement system activation has
the retina. With disease progression, early AMD been detected in AMD patients, independent of
advance to late stages: wet or dry AMD. Wet their genotype [11].
AMD is defined by the presence of neovascular- Due to the strong implications of complement
ization in the retina, while dry AMD is limited to system activation in AMD pathology, various
progressive RPE and retinal atrophy, called geo- complement inhibitors have been tested in clini-
graphic atrophy (GA), without newly formed cal trials. However, most agents that entered
vessels. Around 10% of the cases constitute wet phase II were discontinued due to a reported lack
AMD, and intravitreal anti-VEGF is effective in of efficacy. Interestingly, in some clinical trials, a
treating most cases. However, only recently, group of subjects showed improvements, while
one approved treatment has become available for others did not [12]. Apparently, one of the sus-
dry AMD in the US [2, 8]. pected reasons for the observed lack of efficacy is
The main pathogenetic driver for AMD is a lack of patient’s stratification and identification
advanced age. Specific genetic factors can pre- of those patients that are likely to benefit from
dispose for AMD or protect from it. Unhealthy complement inhibition. Moreover, several stud-
lifestyle habits, like smoking or malnutrition, ies point to a lack of understanding of the role of
can further increase the risk for AMD. The com- FH in AMD pathology, especially in RPE cells,
bination of those risk factors leads to pathologi- which are degenerating in AMD.
cal changes in the retina, involving a plethora of
cellular mechanisms promoting disease pro-
gression [4]. 3 Noncanonical Role
of Complement Factor H
in RPE Cells
2 Complement System in AMD
RPE cells exert several functions vital for retinal
Among the processes involved in AMD, the com- homeostasis, which are impaired in AMD [13].
plement system is associated to AMD at different First of all, RPE cells are responsible for phago-
levels. First of all, many single nucleotide poly- cytosis of shed photoreceptor outer segments
morphisms (SNPs) associated with AMD cluster (POS) and recycling of visual pigments, needed
into genes of the alternative pathway of the com- for a proper visual cycle. This process is energy
plement system with the Complement Factor H intensive, requiring constant mitochondrial res-
(CFH) gene carrying the second highest risk for piration and glycolysis within RPE cells. Due to
AMD [5]. The most common risk haplotype a lack of the inner retina vasculature in the mac-
causes an amino acid substitution from tyrosine ula, RPE cells are vital to ascertain nutrient sup-
to histidine at position 402 (called Y402H) in ply from the choriocapillaris. Any pathological
proteins coded by CFH, which are full length FH disruption or perturbance of metabolic activity
and a truncated version, FHL-1 [6, 7]. The com- of RPE cells would affect the amount of nutri-
plement system is a part of the innate immune ents that can reach the neuroretina. Indeed, the
system designed to recognize and mediate the so-called bioenergetics crisis of RPE cells has
removal of pathogens or waste material [8]. The been described for AMD pathology [14].
eye is an immune-privileged organ, meaning that Moreover, RPE cells quench short UV light as
inflammation needs to be strictly limited, and well as the continuous influx of peroxidized lip-
therefore uncontrolled complement activation is ids from phagocytosed photoreceptor outer seg-
deleterious [8]. FH is a major negative regulator ments and thus need a high degree of antioxidant
of the complement system, and the AMD variant capacity as well as perfect functioning of their
The Noncanonical Role of Complement Factor H in Retinal Pigment Epithelium (RPE) Cells and… 11
mitochondria to protect the retina from exces- [15] or in the presence of the CFH 402H variant
sive oxidative stress. [20]. Moreover, accumulation of lipids was
Our recent work demonstrates that FH is shown also in cfh Y402H mouse models of AMD,
endogenously produced by RPE cells. Within especially when subjected to high cholesterol
RPE cells, FH is acting locally supporting retinal diet [21].
homeostasis [15, 16]. This function of FH is con- The mechanism of action of intracellular FH
text dependent, and we suggest that locally pro- is not fully elucidated. Based on the data gener-
duced FH exerts specific functions at the ated in iPSC-RPE cells carrying the CFH 402H
RPE/retina interface. Most of these newly dis- variant, it has been speculated that more than one
covered functions (summarized in Fig. 1) affect a signaling pathway mediates the effects of FH
balanced regulation of immune competence and [19]. Specifically, it has been postulated that the
surveillance as well as regulating oxidative stress NF-kB pathway and mTOR pathway are likely
response and energy metabolism, mechanisms involved, in concomitance with autophagy and
which are part of AMD pathology [8]. proteasome activity dysregulation, which ulti-
FH plays a protective role against oxidative mately lead to mitochondrial damage [19].
stress in RPE cells. Exogenously applied recom- In our model of CFH-silenced hTERT-RPE1
binant FH protects RPE cells from damage cells, we could verify these hypotheses. Indeed,
induced by the exposure to lipid oxidation prod- we found that in absence of endogenous FH, both
ucts [17, 18]. In parallel, loss of endogenous FH the NF-kB and mTOR pathway are upregulated,
in RPE cells, via CFH silencing, also led to with NF-kB triggering pro-inflammatory cyto-
increased vulnerability to oxidative stress, kine expression [22] and the mTOR pathway
increased levels of oxidized lipids, and reduced modulating mitochondrial respiration, but not
viability [15]. Interestingly, addition of recombi- glycolysis [23]. The mTOR pathway is a major
nant FH in CFH-silenced RPE cells did not cause regulator of autophagy [24]. Dysfunction in the
any rescuing effects [15]. This finding indicates autophagy-lysosomal axis in iPSC-RPE cells
that, although exogenous FH is protective, a with CFH high risk was reported but is not regu-
proper intracellular FH function must be present lated by this pathway. Its dysfunction rather
to ascertain physiological balance and resilience depends on the accumulation of complement
to stress. This phenomenon may be explained by activation products [25]. Based on our analyses
impaired mitochondrial function seen in iPSC- of the intracellular FH protein interactions that
RPE cells carrying the CFH Y402H polymor- form a functional interactome in RPE cells, we
phism [19] and CFH-silenced hTERT-RPE1 cells suggest a regulatory role of FH in interaction
[15]. In both models, major processes involved in with the ubiquitin proteasome system (UPS) and
energy production, glycolysis, and mitochondrial RB1/E2F signaling, adding a new level of com-
respiration are impaired. In addition, a misbal- plexity in the understanding of FH mechanism of
ance in the degree of mitochondria turnover action [23]. Interestingly, and based on studies in
seems to be involved, with an exaggerated other cell types than RPE, it has already been
increase in mitophagy [15, 19]. Moreover, it has suggested that FH has a noncanonical intracellu-
been shown in iPSC-RPE carrying CFH 402H lar function, independent from complement acti-
variant that mitochondria are enlarged and accu- vation. In clear renal cell carcinoma cells and
mulating [20]. Mitochondria are essential for a kidney endothelial cells, FH knockdown impairs
correct response to oxidative stress; therefore, cellular homeostasis, at least partially via NF-kB
damage or dysfunction of these organelles is del- activation [26, 27].
eterious in such an oxidative milieu like the ret- The synopsis of these findings indicates that
ina. Accumulation of oxidized lipids has been understanding the function of FH in a specific
reported in RPE cells under FH dysregulation cell and tissue context is key. In the context of
and induced oxidative stress, when FH function AMD, it is important to advance our understand-
was impaired as a consequence of CFH silencing ing on how RPE cells interact with the neuroret-
12 A. Armento et al.
ina once intracellular FH dysregulation or a CFH ment pathway inhibitor strategy to treat AMD
402H high risk variant perturbs intracellular progression may not suffice. Rational re-balancing
homeostasis within these cells. In this regard, we strategies in a form of combinatorial therapies
have recently established a novel coculture model may be needed to target several drivers of AMD
of RPE and neuroretina. Using this system, we molecular pathology in a systems-oriented fash-
show that CFH-silenced RPE cells promote reti- ion simultaneously. More specifically, the increase
nal degeneration, which could not be rescued by of alternative complement pathway activity at the
the addition of exogenous FH. Moreover, we Bruch’s membrane/RPE interface may have to be
showed that the damage occurred at the level of considered concomitantly with pro-inflammatory,
mitochondrial activity and lipid oxidation in the oxidative stress- related perturbation and meta-
photoreceptors, rather than a canonical inflam- bolic disbalance of RPE and neuroretina to
mation or complement activation [16]. achieve effective future therapeutic regimes for
dry AMD. Last but not least, a very thorough
stratification of patient groups may be needed to
4 Future Perspective move to an individualized and rational therapy for
dry AMD of the future.
Recent works of several groups, including ours,
emphasize a noncanonical and intracellular role
of FH in RPE cells. Besides their reduced capac- References
ity to dampen alternative complement activity,
CFH risk polymorphisms such as Y402H impair 1. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy
U, Chew E, Csaky K, et al. Clinical classification of
RPE homeostasis and are likely contributing to age-related macular degeneration. Ophthalmology.
promote AMD. In consequence, a simple comple- 2013;120(4):844–51.
The Noncanonical Role of Complement Factor H in Retinal Pigment Epithelium (RPE) Cells and… 13
2. van Lookeren Campagne M, LeCouter J, Yaspan BL, porcine retinal explant co-culture model. bioR
Ye W. Mechanisms of age-related macular degen- xiv:2021:2021.07.26.453778.
eration and therapeutic opportunities. J Pathol. 17. Borras C, Canonica J, Jorieux S, Abache T, El
2014;232(2):151–64. Sanharawi M, Klein C, et al. CFH exerts anti-oxidant
3. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng effects on retinal pigment epithelial cells indepen-
CY, et al. Global prevalence of age-related macular dently from protecting against membrane attack com-
degeneration and disease burden projection for 2020 plex. Sci Rep. 2019;9(1):13873.
and 2040: a systematic review and meta-analysis. 18. Krilis M, Qi M, Qi J, Wong JWH, Guymer R,
Lancet Glob Health. 2014;2(2):e106–16. Liew G, et al. Dual roles of different redox forms
4. Armstrong RA, Mousavi M. Overview of risk factors of complement factor H in protecting against age
for age-related macular degeneration (AMD). J Stem related macular degeneration. Free Radic Biol Med.
Cells. 2015;10(3):171–91. 2018;129:237–46.
5. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, 19. Ebeling MC, Geng Z, Kapphahn RJ, Roehrich H,
Curcio CA, Swaroop A. Age-related macular degen- Montezuma SR, Dutton JR, et al. Impaired mitochon-
eration: genetics and biology coming together. Annu drial function in iPSC-retinal pigment epithelium
Rev Genomics Hum Genet. 2014;15:151–71. with the complement factor H polymorphism for age-
6. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, related macular degeneration. Cell. 2021;10(4):789.
Haynes C, et al. Complement factor H polymor- 20. Hallam D, Collin J, Bojic S, Chichagova V, Buskin A,
phism in age-related macular degeneration. Science. Xu Y, et al. An induced pluripotent stem cell patient
2005;308(5720):385–9. specific model of complement factor H (Y402H)
7. Day AJ, Willis AC, Ripoche J, Sim RB. Sequence polymorphism displays characteristic features of
polymorphism of human complement factor age-related macular degeneration and indicates a
H. Immunogenetics. 1988;27(3):211–4. beneficial role for UV light exposure. Stem Cells.
8. Armento A, Ueffing M, Clark SJ. The complement 2017;35(11):2305–20.
system in age-related macular degeneration. Cell Mol 21. Ding JD, Kelly U, Groelle M, Christenbury JG, Zhang
Life Sci. 2021;78(10):4487–505. W, Bowes Rickman C. The role of complement dys-
9. Skerka C, Lauer N, Weinberger AA, Keilhauer regulation in AMD mouse models. Adv Exp Med
CN, Suhnel J, Smith R, et al. Defective comple- Biol. 2014;801:213–9.
ment control of factor H (Y402H) and FHL-1 in 22. Armento A, Schmidt TL, Sonntag I, Merle DA,
age-related macular degeneration. Mol Immunol. Jarboui MA, Kilger E, et al. CFH loss in human RPE
2007;44(13):3398–406. cells leads to inflammation and complement system
10. Mullins RF, Russell SR, Anderson DH, Hageman dysregulation via the NF-kappaB pathway. Int J Mol
GS. Drusen associated with aging and age-related Sci. 2021;22(16):8727.
macular degeneration contain proteins common to 23. Merle D, Provenzano F, Jarboui MA, Kilger E, Clark
extracellular deposits associated with atherosclero- S, Deleidi M, et al. mTOR inhibition via Rapamycin
sis, elastosis, amyloidosis, and dense deposit disease. treatment partially reverts the deficit in energy
FASEB J. 2000;14(7):835–46. metabolism caused by FH loss in RPE cells. bioR
11. Heesterbeek TJ, Lechanteur YTE, Lores-Motta L, xiv:2021:2021.10.29.466270.
Schick T, Daha MR, Altay L, et al. Complement 24. Wang Y, Zhang H. Regulation of autophagy by mTOR
activation levels are related to disease stage in signaling pathway. In: Qin Z-H, editor. Autophagy:
AMD. Invest Ophthalmol Vis Sci. 2020;61(3):18. biology and diseases: basic science. Singapore:
12. Park DH, Connor KM, Lambris JD. The challenges Springer; 2019. p. 67–83.
and promise of complement therapeutics for ocular 25. Cerniauskas E, Kurzawa-Akanbi M, Xie L, Hallam D,
diseases. Front Immunol. 2019;10:1007. Moya-Molina M, White K, et al. Complement modu-
13. Strauss O. The retinal pigment epithelium in visual lation reverses pathology in Y402H-retinal pigment
function. Physiol Rev. 2005;85(3):845–81. epithelium cell model of age-related macular degen-
14. Fisher CR, Ferrington DA. Perspective on AMD eration by restoring lysosomal function. Stem Cells
pathobiology: a bioenergetic crisis in the RPE. Invest Transl Med. 2020;9(12):1585–603.
Ophthalmol Vis Sci. 2018;59(4):AMD41–AMD7. 26. Daugan MV, Revel M, Thouenon R, Dragon-Durey
15. Armento A, Honisch S, Panagiotakopoulou V, MA, Robe-Rybkine T, Torset C, et al. Intracellular
Sonntag I, Jacob A, Bolz S, et al. Loss of comple- factor H drives tumor progression independently
ment factor H impairs antioxidant capacity and of the complement cascade. Cancer Immunol Res.
energy metabolism of human RPE cells. Sci Rep. 2021;9:909–25.
2020;10(1):10320. 27. Mahajan S, Jacob A, Kelkar A, Chang A, McSkimming
16. Armento A, Murali A, Marzi J, Arrango-Gonzalez D, Neelamegham S, et al. Local complement factor H
B, Kilger E, Clark SJ, et al. FH loss in RPE cells protects kidney endothelial cell structure and func-
causes retinal degeneration in a human RPE- tion. Kidney Int. 2021;100(4):824–36.
Macular Pigment Carotenoids
and Bisretinoid A2E
Abstract Keywords
Lutein (L), zeaxanthin (Z), and meso- Abca4 · A2E · Antioxidant · Bisretinoids ·
zeaxanthin (MZ) are the three macular pig- Carotenoids · Lipofuscin · Macular pigments
ments (MP) carotenoids that uniquely · Photo-oxidation · Retina · Retinal pigment
accumulate in the macula lutea region of the epithelium
human retina. L and Z are obtained by humans
through dietary intake. The third MP, MZ, is
rarely present in diet, and its abundance in the 1 Introduction
human fovea is due to the metabolic conver-
sion of dietary L by the retinal pigment epithe- Carotenoids are natural pigments synthesized by
lium’s RPE65 enzyme. The major functions of photosynthetic bacteria, algae, yeast, and plants.
MP in ocular health are to filter high-intensity, L, Z, and MZ are oxygenated carotenoids (xan-
phototoxic blue light and to act as effective thophylls) obtained by humans through dietary
antioxidants for scavenging free radicals. The intake of leafy greens, fruits, and vegetables.
pyridinium bisretinoid, N-retinylidene-N- Among the 15 major dietary carotenoids detected
retinylethanolamine (A2E), contributes to in human serum, these three xanthophyll carot-
drusen formation in dry age-related macular enoids selectively accumulate with a unique dis-
degeneration (AMD) and to the autofluores- tribution in the macular region of human retina
cent flecks in autosomal recessive Stargardt [1]. The MP’s total concentration is about 1 mM
disease (STGD1). Retinal carotenoids attenu- at the fovea, and its concentration declines to less
ate A2E formation and can directly and indi- than 10 μM in the peripheral retina [2]. The ratio
rectly alleviate A2E-mediated oxidative of L:Z:MZ in the peripheral retina is about 3:1:0,
damage. In this chapter, we review these more and the concentration of total carotenoids rises
recently recognized interconnections between 100-fold in the macula lutea with a change in the
MP carotenoids and A2E bisretinoids. ratio of L:Z:MZ of about 1:1:1, as measured by
high-performance liquid chromatography
(HPLC) [3]. More recently, high-resolution con-
R. Arunkumar · P. S. Bernstein (*) focal resonance Raman microscopy imaging of
Department of Ophthalmology and Visual Sciences, the human retina from our laboratory has showed
John A. Moran Eye Center, University of Utah that the ratio of Z + MZ:L can be greater than 9:1
School of Medicine, Salt Lake City, UT, USA at the foveal center, while L is more diffusely dis-
e-mail: paul.bernstein@hsc.utah.edu
tributed across the macula at a relatively lower aided by conjugated double-bond structure with
concentration [4]. Retinal carotenoids mainly the hydrophilic group on the ionone ring [2]. The
localize to the outer plexiform (Henle fiber) layer absorption maximum of L is around 445 nm, and
and the inner plexiform layer, with axial exten- Z is around 450 nm, corresponding with the haz-
sion from the inner limiting membrane to the ardous blue light range of 430–500 nm.
outer limiting membrane. The specificity in the Depending on the retinal carotenoid concentra-
distribution of retinal carotenoids in the human tion, they are estimated to absorb 40–90% of
retina may be due to the selective uptake of reti- incident short-wavelength, high-energy photo-
nal carotenoids by carotenoid binding proteins toxic blue light [8].
StARD3 (L binding protein) and GSTP1 (Z and Retinal carotenoids with conjugated double
MZ binding protein). The other major factors that bond (C=C) structures are associated with greater
influence the MP carotenoid distributions and singlet oxygen quenching. Z has 11 conjugated
concentrations between individuals are the double bonds and is 50% better at quenching sin-
amount of oral intake of carotenoids and their glet oxygen relative to L with its 10-conjugated
bioavailability [5]. L is present in higher concen- double bonds [9]. MZ, a stereoisomer of Z, with
trations in the diet, but it is converted to MZ by an identical 11-conjugated double-bond structure
the RPE65 enzyme, and the preferential accumu- would be expected to possess the same antioxi-
lation of Z and MZ at the foveal center may be dant properties as Z, but it exhibited better singlet
due to their higher antioxidant potential relative oxygen quenching properties relative to L and Z
to L. The fovea is prone to photo-damage caused [9]. Furthermore, the antioxidant activity of all
by light-induced oxidative stress from reactive three retinal carotenoids as a mixture showed bet-
oxygen species, and singlet oxygen can be gener- ter singlet oxygen quenching ability than any of
ated by photo-oxidation of A2E and other bisreti- the individual MP carotenoids. Retinal carot-
noid components of lipofuscin [6]. A2E acts as a enoids not only quench singlet oxygen, but they
photosensitizer in the presence of short- also quench superoxide anion radicals and
wavelength blue light and oxygen that generate hydroxyl radicals, the major causative agents of
reactive oxygen caused by photo-oxidation and lipid peroxidation and light-induced damage [10,
photo-degradation, resulting in retinal degenera- 11]. Generally, retinal carotenoids are better
tion and apoptosis of photoreceptor and RPE hydroxyl radical scavengers than superoxide
cells [7]. Supplementation with retinal carot- anion scavengers, and Z exhibits better hydroxyl
enoids potentially attenuates harmful blue light radical scavenging activity than lutein [10]. MP
and effectively scavenges singlet oxygen and carotenoids protect the retina, which is vulnera-
reactive free radicals in ocular tissues and in bio- ble to oxidative damage caused by exposure to
chemical assays. light, high concentration of oxygen, abundant
photosensitizers, and high concentrations of
polyunsaturated fatty acids (PUFAs).
2 Structure and Function
of the Retinal Carotenoids
3 A2E Bisretinoids
Retinal carotenoids are characterized by the pres-
ence of hydroxyl (O-H) functional groups In the visual cycle, the activation of rhodopsin by
attached at the 3 and 3′ positions of terminal ion- a photon of light during phototransduction results
one rings connected by an isoprenoid backbone in the isomerization of 11-cis-retinal to all-trans-
structure (Fig. 1). The presence of hydroxyl retinal in photoreceptor outer segments and the
groups and the conjugated double bonds struc- release of all-trans-retinal, which is subsequently
ture determine the light-absorbing properties and reduced to all-trans-retinol and transported to the
antioxidant activities of retinal carotenoids. The RPE cells. In the RPE, the all-trans-retinol is
light filtering function of retinal carotenoids is either stored as a fatty acid ester or is converted
Macular Pigment Carotenoids and Bisretinoid A2E 17
OH
HO
Lutein
OH
HO
Zeaxanthin OH
N
OH
A2E
HO
Meso-Zeaxanthin
Fig. 1 Structures of the macular carotenoids: lutein (L), zeaxanthin (Z), meso-zeaxanthin (MZ), and N-retinylidene-N-
retinylethanolamine (A2E)
back to an 11-cis-retinoid that is transported back RPE, A2PE is further hydrolyzed to A2E by
to the photoreceptor outer segment, which can phospholipase D inside RPE phagosomes.
bind to opsin to produce a regenerated visual pig- Mutation or dysfunction in the ABCA4 gene
ment. Some all-trans-retinal in the photoreceptor leads to excessive accumulation of A2E and other
outer segments reacts with phosphatidylethanol- bisretinoids in RPE lipofuscin, resulting in reti-
amine (PE) to form N-retinylidene-PE (NRPE), nal cell death and vision loss. A2E is reported to
which is transported or “flipped” by the ATP- accumulate with aging and dry AMD and in
binding cassette, subfamily A, member 4 STGD1 [13].
(ABCA4) protein present in photoreceptor outer A2E (C42H58ON; molecular weight, 592) is a
segments. ABCA4 translocates NRPE across the well-characterized component of lipofuscin. It
lipid bilayer from the luminal side to the cyto- exhibits absorbance in both the UV and visible
plasmic side of the disc membrane. NRPE regions of the spectrum [A2E: absorbance max-
released on the cytoplasmic side is hydrolyzed ima (λmax) are 440 and 340 nm, and iso-A2E’s
into all-trans-retinal and reduced to all-trans- λmax are 430 and 340 nm]. A2E’s hydrophobic
retinol by retinol dehydrogenases (RDHs) [12]. If side arms and positively charged hydrophilic
ABCA4 does not effectively translocate NRPE, it head group confer an amphiphilic structure
reacts with one more molecule of all-trans-retinal (Fig. 1). A2E has a detergent-like structure that
to form a toxic bisretinoid, dihydropyridinium- may influence membrane properties and inhibit
A2PE. Dihydropyridinium-A2PE is further the lysosomal degradation of lipids. A2E induces
oxidized either to A2-dihydropyridine-PE
loss of membrane integrity and perturbs mem-
(A2-DHP-PE) by eliminating one hydrogen or to brane stability, and it inhibits cytochrome C oxy-
phosphatidylethanolamine-pyridinium bisreti- genase and the ATP-driven proton pump. A2E
noid (A2PE) by eliminating two hydrogens in the photo-oxidation products can activate the com-
acidic and oxidizing environment (Fig. 2). During plement system and cause inflammation and
phagocytosis of photoreceptor outer segments by DNA damage [12, 13].
18 R. Arunkumar and P. S. Bernstein
Fig. 2 The visual cycle and bisretinoid formation in pho- hydrogens generates A2PE, and loss of one hydrogen gen-
toreceptor outer segments and RPE. When a photon of erates A2-DHP-PE; phosphate hydrolysis of the latter
light is captured by the visual chromophore, its 11-cis- produces A2-DHP-E. A2E, lysoA2PE, and A2-GPE are
retinal (11-cis-RAL) Schiff base chromophore photoi- produced from A2PE. Reaction of the all-trans-RAL
somerizes to all-trans-retinal (all-trans-RAL). The dimer with PE with the formation of a Schiff base linkage
released all-trans-RAL from opsin is reduced to all-trans- generates all-trans-retinal dimer-PE (atRALdi-PE), and
retinol (all-trans-ROL) by retinol dehydrogenases phosphate hydrolysis of the latter yields all-trans-retinal
(RDHs). Alternatively, some all-trans-RAL reacts with dimer-ethanolamine (atRALdi-E). All-trans-ROL is
phosphatidylethanolamine (PE) in the photoreceptor outer transported into RPE cells where all-trans-ROL is esteri-
segments to form N-retinylidene-PE (NRPE), which is fied to fatty acids to make all-trans retinyl esters (all-
transported by ABCA4. The bisretinoid synthesis path- trans-RE) by the enzyme lecithin retinol acyl transferase
way (red) is initiated when NRPE, rather than hydrolyzing (LRAT). All-trans-RE is converted to 11-cis retinol
to all-trans-ROL and PE, reacts with a second molecule of (11-cis-ROL) by the RPE65 isomerohydrolase. 11-cis
retinaldehyde. A multistep pathway leads to the formation retinol dehydrogenase (11cRDH) oxidizes 11-cis-ROL to
of the intermediate dihydropyridinium-A2PE. Auto- 11-cis-RAL which enters the photoreceptor outer seg-
oxidation of dihydropyridinium-A2PE with loss of two ments for the regeneration of opsin
in human tissue [2]. MMPs typically have an The specific interplay of pathophysiological
80-amino acid propeptide, a 170-amino acid cat- events that converge to AMD and related degen-
alytic metalloproteinase domain, a variable- eration mechanisms remain to be fully elucidated
length linker peptide (hinge region), and a [11]. Nevertheless, several studies have been
200-amino acid hemopexin (Hpx) domain. A highlighting the alterations in the regulation of
detailed description of MMPs structure and an ECM, by dysregulation of the activity of MMPs
overview of their substrate preferences and their and TIMPs, as one of the main mechanisms
association with extracellular matrix (ECM) com- involved in the development of AMD [12]. This
ponents and inhibitors can be found in other modulation of ECM turnover is associated with
excellent reports [2–4]. the other molecular mechanisms involved in the
The MMPs are usually secreted as zymogens pathophysiology of the disease since some stud-
by a variety of cells into the extracellular space ies have shown that both oxidative stress and acti-
[3] or stay tethered to their plasma membrane [5]. vation of the complement system can modulate
In humans, there are six membrane-type (MT)- the activity of ECM components [13, 14].
MMPs [5]. In the generation of active MMPs, Additionally, the formation of drusen, the hall-
enzymatic cleavages of the zymogens are needed. mark of AMD, is also believed to be associated
Active MMP-2, for example, is made from pro- with a dysregulation of the ECM components,
MMP-2 by MMP-14 cleavage, while pro-MMP-9 especially in the RPE and Bruch’s membrane
is cleaved by MMP-3 [5, 6]. (BM) [15]. These alterations in ECM modulation
MMPs are mainly classified based on their caused by dysregulation of MMP/TIMP complex
substrate preference and domain organization, can also be influenced not only by environmental
being grouped into gelatinases (MMP-2, MMP- but also by genetic factors. For example, poly-
9), collagenases (MMP-1, MMP-8, MMP-13), morphisms in MMP-2 (rs243865) and in MMP-9
stromelysins (MMP-3, MMP-10), MT-MMPs (rs3918424 and rs3918241) are associated with
(MMP-14, MMP-15, MMP-16, MMP-17), and increased risk of AMD, mainly in younger
others [7]. Under normal conditions, both MMPs patients (<65 years) [16–18]. Other MMP-2
and the tissue inhibitors of metalloproteinases polymorphisms (rs243865, rs243866, and
(TIMPs) have an important role in the regulation rs2287074) are associated with a lower likeli-
of the turnover of ECM [2, 8]. A dysregulation of hood of AMD development [19, 20]. There are
these components can both contribute to patho- also some TIMPs polymorphisms associated
logical ECM remodeling and serve as a nexus for with AMD. Despite some polymorphisms in
a variety of pathways involved in age-related TIMP-2 (rs817909) and in TIMP-3 (rs5754227)
macular degeneration (AMD) pathogenesis. appear to have a protective effect, other polymor-
phisms in TIMP-3 (rs713685 and rs743751) are
more frequent in AMD patients [18, 21, 22]. As a
2 MMPs Are Implicated in AMD result, these findings highlight evidence that
changes in ECM turnover are essential mecha-
AMD is a retinal degenerative disease that is a nisms implicated in the development of AMD
leading cause of central vision loss in the elderly. and may help explain the susceptibility to the dis-
This disease, in its early stages, is characterized ease’s late stages.
by the accumulation of drusen that causes pro-
gressive degeneration of the photoreceptors and
retinal pigment epithelium (RPE). The disease 2.1 MMPs in Dry AMD
can progress to geographic atrophy (GA), an
advanced form of dry AMD, and/or choroidal BM is a five-layered ECM located at the inter-
neovascularization (CNV), also known as wet face of the retina and choriocapillaris. BM plays
AMD [9, 10]. an important role in cell-cell communication and
Disturbed Matrix Metalloproteinases Activity in Age-Related Macular Degeneration 23
regulates the exchange of oxygen and nutrients oxygen supply to the outer retina. The oxidative
between the choroid and the outer retina [23]. and inflammatory processes that occur in late
However, BM undergoes a number of age-related stages of AMD might promote a pro-angiogenic
alterations that may have a role in AMD patho- environment, resulting in CNV, which is the hall-
genesis. Especially noteworthy, the accumulation mark of wet AMD. Neovessels from choroid,
of cellular debris and ECM proteins leads BM to also referred as CNV, develop beneath the RPE
thicken and to the formation of drusen [24]. or penetrate into the subretinal space in patients
Several studies have been demonstrated that with wet AMD [38, 39].
aging causes structural and functional changes in Similar to GA and BM thickness, in this case
the BM due to a decrease in the activity of the also dysregulation of ECM turnover appears to
gelatinase components of the MMP system. In have a close relation with CNV. Increased activ-
this case, increased levels of high molecular ity of MMPs can degrade some components of
weight components of the MMPs pathway BM, essential to the growth of new vessels [40,
(HMW1 and HMW2) reduce the pool of the acti- 41]. Several studies have shown that patients with
vated gelatinases MMP-2 and MMP-9 and con- wet AMD present increased levels of MMP-9 in
tribute to reduced matrix degradation and aqueous humor, vitreous, and plasma [42–44].
thickness of BM [25–27]. Another study revealed This increase in the levels of MMP-9 contributes
that higher TIMP-3 concentrations in the drusen to CNV since this MMP can increase VEGF lev-
block MMPs activity, lowering proteolytic activ- els (pro-angiogenic factor) by decreasing PEDF
ity within the drusen [28]. Oxidative stress levels (anti-angiogenic factor), both secreted by
reduces MMP-2 activity and leads to the forma- the RPE [45]. MMP-2, MMP-7, and MMP-13
tion of sub-RPE deposits that can be involved in have likewise shown a rise in their expression and
the formation of drusen during AMD develop- levels in patients with CNV lesions [18, 46, 47].
ment [29]. Moreover, cellular and animal models of CNV
Nevertheless, several other studies also lesions reported increased expression of MMP-2
detected increased levels of other MMPs in and MMP-9, which were involved in the forma-
patients with GA. MMP-7 levels were found to tion of experimental CNV. Additionally, the inhi-
be lower in these patients, but MMP-9 and bition of these two gelatinases appears to be a
TIMP-1 levels were higher [30, 31]. In vitro and good strategy to treat CNV, since their elimina-
in vivo models of dry AMD led to increased tion is associated with decreased CNV lesion size
expression, secretion, and activation of MMP-1, [48–50]. Some studies have also been underlin-
MMP-3, and MMP-9 and are associated with ing the alterations in TIMPs activity as an impor-
decreased RPE cell viability [32–34]. Moreover, tant mechanism underlying CNV. On both wet
MMP-9’s role in the breakdown of the RPE bar- AMD patients and animal models, decreased lev-
rier has been highlighted, as silencing of this els of TIMPs (TIMP-2 and TIMP-3) contribute to
MMP can improve the barrier integrity [35, 36]. CNV susceptibility [18, 51].
Regarding genetic alterations, only a few stud- Regarding genetic alterations, several studies
ies have related polymorphisms specifically with identified various polymorphisms on both MMPs
dry AMD. Liutkeviciene et al. detected that a and TIMPs that are related to CNV and wet
polymorphism in the MMP-2 gene (rd243865) is AMD. Microsatellites in the promoter of MMP-
associated with the development of hard drusen 9, along with other polymorphisms on the
in AMD patients [37]. MMP-9 gene (rs142450006, rs3918424), have
been associated with increased risk of CNV pro-
gression and wet AMD development [17, 52, 53].
2.2 MMPs in Wet AMD Also polymorphisms on MMP-1 (rs1799750),
MMP-2 (rs243865), MMP-7 (rs11568818), and
The choroid is a network of blood vessels, located MMP-20 (rs10895322) are associated with
below the BM that is critical for nutrients and increased CNV lesion size and development of
24 B. Martins and R. Fernandes
wet AMD [54–56]. Finally, a polymorphism in 8. Agren MS, Auf dem Keller U. Matrix metallo-
proteinases: how much can they do? Int J Mol Sci.
the TIMP-3 gene (rs9621532) has a protective 2020;21(8):2678.
effect and is associated with decreased risk of 9. Mitchell P, Liew G, Gopinath B, Wong
wet AMD [57]. TY. Age-related macular degeneration. Lancet.
2018;392(10153):1147–59.
10. Al-Zamil WM, Yassin SA. Recent developments
in age-related macular degeneration: a review. Clin
3 Concluding Remarks Interv Aging. 2017;12:1313–30.
11. Ambati J, Fowler BJ. Mechanisms of age-related
Due to their ability to break down ECM constitu- macular degeneration. Neuron. 2012;75(1):26–39.
12. Peng H, Hulleman JD. Prospective application of
ents, MMPs are relevant components in many activity-based proteomic profiling in vision research-
pathological processes of AMD. Specifically, potential unique insights into ocular protease biology
they play an important role in the accumulation and pathology. Int J Mol Sci. 2019;20(16):3855.
of drusen and degeneration of photoreceptors/RPE 13. Klettner A. Oxidative stress induced cellular sig-
naling in RPE cells. Front Biosci (Schol Ed).
in dry AMD and pathological vessel growth in 2012;4:392–411.
wet AMD. TIMPs control changes in their 14. Fernandez-Godino R, Pierce EA. C3a triggers for-
expression and activity. To better understand the mation of sub-retinal pigment epithelium depos-
role of each MMP in AMD pathogenesis, further its via the ubiquitin proteasome pathway. Sci Rep.
2018;8(1):9679.
research is needed. 15. Luibl V, Isas JM, Kayed R, Glabe CG, Langen R,
Chen J. Drusen deposits associated with aging and
Acknowledgments Funding provided by the Global age-related macular degeneration contain nonfibrillar
Ophthalmology Awards Program (GOAP), a Bayer spon- amyloid oligomers. J Clin Invest. 2006;116(2):378–85.
sored initiative committed to supporting ophthalmic 16. Liutkeviciene R, Lesauskaite V, Zaliaduonyte-
research across the world. Thanks are also due to FCT Peksiene D, et al. Role of MMP-2 (-1306 C/T)
(Portugal) and Strategic Projects UIDB/04539/2020 and polymorphism in age-related macular degeneration.
UIDP/04539/2020 (CIBB), COMPETE-FEDER (POCI- Ophthalmic Genet. 2016;37(2):170–6.
01-0145-FEDER-007440), and Centro 2020 Regional 17. Liutkeviciene R, Lesauskaite V, Sinkunaite-
Operational Program: BRAINHEALTH 2020 Marsalkiene G, et al. The role of matrix metallo-
(CENTRO-01-0145- FEDER-000008). The authors also proteinases polymorphisms in age-related macular
acknowledge FCT for the doctoral research grant degeneration. Ophthalmic Genet. 2015;36(2):149–55.
2020.04811.BD (to B.M.). 18. Oszajca K, Szemraj M, Szemraj J, Jurowski
P. Association analysis of genetic polymorphisms and
expression levels of selected genes involved in extra-
cellular matrix turnover and angiogenesis with the
References risk of age-related macular degeneration. Ophthalmic
Genet. 2018;39(6):684–98.
1. Goodwin L. A closer look at metalloproteinases. 19. Cheng J, Hao X, Zhang Z. Risk of macular degen-
Hauppauge: Nova Science Publisher Inc; 2019. 310 p eration affected by polymorphisms in Matrix
2. Laronha H, Caldeira J. Structure and function of human metalloproteinase-2: a case-control study in
matrix metalloproteinases. Cell. 2020;9(5):1076. Chinese Han population. Medicine (Baltimore).
3. Cui N, Hu M, Khalil RA. Biochemical and biological 2017;96(47):e8190.
attributes of matrix metalloproteinases. Prog Mol Biol 20. Seitzman RL, Mahajan VB, Mangione C, et al.
Transl Sci. 2017;147:1–73. Estrogen receptor alpha and matrix metallo-
4. Maskos K. Crystal structures of MMPs in complex proteinase 2 polymorphisms and age-related
with physiological and pharmacological inhibitors. maculopathy in older women. Am J Epidemiol.
Biochimie. 2005;87(3-4):249–63. 2008;167(10):1217–25.
5. Itoh Y. Membrane-type matrix metalloprotein- 21. Fritsche LG, Igl W, Bailey JN, et al. A large genome-
ases: their functions and regulations. Matrix Biol. wide association study of age-related macular degen-
2015;44–46:207–23. eration highlights contributions of rare and common
6. Wilcock DM, Morgan D, Gordon MN, et al. Activation variants. Nat Genet. 2016;48(2):134–43.
of matrix metalloproteinases following anti-Abeta 22. Kaur I, Rathi S, Chakrabarti S. Variations in TIMP3
immunotherapy; implications for microhemorrhage are associated with age-related macular degeneration.
occurrence. J Neuroinflammation. 2011;8:115. Proc Natl Acad Sci U S A. 2010;107(28):E112–3.
7. Nagase H, Visse R, Murphy G. Structure and function 23. Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen
of matrix metalloproteinases and TIMPs. Cardiovasc AA. The dynamic nature of Bruch’s membrane. Prog
Res. 2006;69(3):562–73. Retin Eye Res. 2010;29(1):1–18.
Disturbed Matrix Metalloproteinases Activity in Age-Related Macular Degeneration 25
53. Lauwen S, Lefeber DJ, Fauser S, Hoyng CB, den neovascular lesion size in age-related macular
Hollander AI. Increased pro-MMP9 plasma levels degeneration. Ophthalmology. 2015;122(11):2295–
are associated with neovascular age-related macular 302 e2.
degeneration and with the risk allele of rs142450006 56. Liutkeviciene R, Vilkeviciute A, Borisovaite D,
near MMP9. Mol Vis. 2021;27:142–50. Miniauskiene G. Association of exudative age-related
54. Budiene B, Liutkeviciene R, Gustiene O, et al. The macular degeneration with matrix metalloproteinases-
association of matrix metalloproteinases poly- 2 (-1306 C/T) rs243865 gene polymorphism. Indian J
morphisms and interleukins in advanced age- Ophthalmol. 2018;66(4):551–7.
related macular degeneration. Ophthalmic Genet. 57. Ardeljan D, Meyerle CB, Agron E, et al. Influence of
2018;39(4):463–72. TIMP3/SYN3 polymorphisms on the phenotypic pre-
55. Akagi-Kurashige Y, Yamashiro K, Gotoh N, et al. sentation of age-related macular degeneration. Eur J
MMP20 and ARMS2/HTRA1 are associated with Hum Genet. 2013;21(10):1152–7.
Current Views on Chr10q26
Contribution to Age-Related
Macular Degeneration
Abstract 1 Introduction
tory [28, 36], dietary choices [30, 37–40], race 2.1 Reported Tissue, Cellular
and ethnicity [41–43], gender [21], and smoking and Subcellular Expression
[25, 44–46]. In addition, genetic factors explain of ARMS2/ARMS2
46–71% of the variation in overall disease sever-
ity [47]. To date, a total of 52 independently asso- The expression of ARMS2 was detected in pla-
ciated common and rare gene variants cental tissue [55], at low levels in retinal samples
(p < 5 × 10−8), distributed across 34 loci, have [56, 73] and later, ubiquitously, in human tissues
been associated with AMD risk [48–51]. [77]. The Bgee gene expression database (v14.2)
Genome-wide association (GWA) and family- currently lists 62 distinct human tissues with
based linkage studies identified genetic variants varying ARMS2 mRNA levels [78].
in the complement factor H (CFH) gene on Kanda et al. expressed human retinal ARMS2
Chr1q32 and two tightly linked genes—ARMS2 mRNA in COS-1, ARPE-19, and JEG cells.
and HTRA1—on Chr10q26 as major contributors Subcellular fractionation, followed by co-staining
to AMD risk [52–65]. Together, these increase with MitoTracker and cytochrome C oxidase
AMD predisposition by more than 40-fold [66]. subunit IV, located ARMS2 to the mitochondrial
While significant progress has been made toward (Mt) outer membrane [73]. Subsequently, another
understanding the role of CFH in AMD risk [67– group co-stained ARMS2 with retinoschisin (an
70], uncertainty remains regarding the gene(s) extracellular protein that stains PR inner seg-
responsible at the Chr10q26 locus. Strong link- ments) and Mt cytochrome c oxidase subunit II in
age disequilibrium between ARMS2 and HTRA1 human retinal sections. ARMS2 localized in the
genes has made it difficult to distinguish individ- Mt-enriched ellipsoid region of the inner seg-
ual gene effects by statistical methods [71]. ments of both rod and cone PR cells [79].
Moreover, PLEKHA1 is also found in linkage However, conflicting results were presented by
disequilibrium with ARMS2 [55]. Several studies Wang et al. [80]. Using immunofluorescence
suggest that ARMS2/HTRA1 genetic variations (IF), verified by immunoblotting, endogenous
are more strongly associated with AMD risk than ARMS2 in ARPE-19 cells and overexpressed
PLEKHA1 [56, 72, 73]. In this chapter, we review GFP-tagged and HIS-tagged exogenous ARMS2
existing information about ARMS2 and HTRA1 in COS7 cells were found to localize in the cyto-
and their association with AMD. sol and not in Mt or any other organelle [80]. The
group further performed in silico analyses to
identify the protein features required for Mt tar-
2
ARMS2 geting and concluded that ARMS2 lacked canon-
ical mitochondrial targeting sequences [80].
The ARMS2 gene, age-related maculopathy sus- Kortvely et al. transfected HEK293 cells with
ceptibility 2, is only present in higher primates plasmid constructs coding for normal or risk vari-
[74]. ARMS2 encodes an 11-kDa protein [75]; ant ARMS2. Immunostaining findings suggested
however the function, localization, and native that ARMS2 is a secreted protein and a compo-
structure of the protein have not been firmly nent of the extracellular matrix (ECM), found
established. An in silico approach to predict the mainly in choroid pillars of human eye [81].
structure of ARMS2 concluded that it has 15 Using a yeast two-hybrid system, followed by
putative phosphorylation sites, four putative gly- coprecipitation, ARMS2 was found to bind sev-
cation sites of ε-amino groups of lysine, two eral ECM proteins [81]. Further, ARMS2 colo-
putative O-linked glycation sites, and three calized with the endoplasmic reticulum (ER) in
potential binding sites [76]. The alanine at posi- transfected ARPE-19 cells expressing ARMS2.
tion 69 is predicted to be a functional residue for Adding a small N-terminal tag to ARMS2 did not
protein binding. have any effect, whereas the same tag at the
Current Views on Chr10q26 Contribution to Age-Related Macular Degeneration 29
C-terminus abolished ER colocalization, indicat- to human apoptotic and necrotic cells and initiate
ing that the C-terminus is integral to proper properdin-mediated complement activation and
targeting [81]. A follow-up study concluded that C3b surface opsonization for phagocytosis [75].
ARMS2 is secreted via an unconventional, Golgi- Two additional variants of ARMS2 have been
independent pathway. Blocking the canonical ER reported: an insertion-deletion (indel) polymor-
to Golgi transport did not affect ARMS2 secre- phism (NM_001099667.1:c.*372_815del443
tion. Instead, ARMS2 was shown to colocalize ins54) in the 3′untranslated region (3′-UTR) and
with calnexin-positive and protein disulfide a coding nonsense polymorphism (R38X) [79].
isomerase-negative vesicle-like structures and, The ARMS2 indel lies within the HTRA1 cis-
with GRASP65, a marker for unconventional regulatory region, upstream of its transcription
protein secretion. Exon 2 of ARMS2 codes for start site [83, 84], and is suggested to regulate
eight amino acids (-SIIHTAAR) at the HTRA1 expression. In heterozygous retinal and
C-terminus. By generating a set of mutants, the placental samples from human donors, Fritsche
two isoleucines were found to be indispensable et al. showed that this indel mutation destabilizes
for correct targeting. The intracellular distribu- the ARMS2 transcript by removing the polyade-
tion of the A69S risk allele was similar to the nylation signal and inserting a 54-bp element
non-risk allele, with both protein variants secreted known to mediate rapid mRNA turnover [79].
into the culture medium [82]. The group validated their findings by developing
Micklisch et al. found endogenous ARMS2 recombinant ARMS2 isoforms, quantifying heter-
gene expression in human blood-derived mono- ologous ARMS2 expression in vitro and conclud-
cytes and in human-induced pluripotent stem ing that the indel polymorphism in ARMS2 leads
cell-derived microglia (iPSdM) by PCR and laser to reduced mRNA levels [83].
scanning microscopy. Contrary to the study by The ARMS2 variant identified by Fritsche
Kortvely et al. which showed translation of the et al., rs2736911(C>T:R38X), is predicted to
ARMS2 A69S variant, this study reported that result in a premature stop codon (R38X) and a
ARMS2 protein was absent in patients homozy- truncated protein [79]. Yang et al. observed a
gous for the ARMS2 AMD risk variant A69S or 50% decrease in mRNA in patients heterozygous
the non-risk variant R38X [75]. for R38X [85], presumably due to nonsense-
mediated mRNA decay. They reasoned that the
loss of ARMS2 is insufficient to explain AMD
2.2
ARMS2 Risk Variants and Their susceptibility as both the indel and R38X variants
Putative Role in AMD result in a decrease in ARMS2, but only the for-
mer confers risk to AMD, while the latter is
The missense variant, rs10490924 (G>T:A69S) mildly protective [85, 86]. This led to a hypothe-
[73, 80, 82], encoding an alanine-to-serine sub- sis of dual causality, in which concomitant down-
stitution at position 69 (A69S) is the most fre- regulation of ARMS2 and upregulation of HTRA1
quently observed ARMS2 risk allele in the human explains the disease [85]. Similar results were
population. Little is known about the effect of obtained in another study that showed reduced
this mutation on ARMS2 protein structure and ARMS2 expression in human postmortem retinal
function. One study reports that the A69S varia- and RPE samples, heterozygous for R38X [83].
tion in ARMS2 creates a new putative phosphory- However, a subsequent investigation failed to
lation site that breaks a predicted α-helix [73]. It detect a rs2736911-dependent alteration in
has been suggested that the A69S change affects ARMS2 expression [87].
ARMS2’s function in either Mt [73, 79] or its Since ARMS2 is not found in mice, to gain a
role in the cytoskeleton in COS7cells [80]. A better understanding of ARMS2 function, two
recent study implicated ARMS2 as a surface com- transgenic mouse models expressing human
plement regulator [75]. Recombinant ARMS2, ARMS2 and ARMS2 A69S were developed. The
expressed in Pichia pastoris, was shown to bind constructs used a ubiquitous cytomegalovirus
Another random document with
no related content on Scribd:
The car passed the ornamental ponds, in which the colliers threw
their newspapers, and took the private drive to the house. It stood
above, aside, a very pleasant stucco building from the middle of the
eighteenth century. It had a beautiful alley of yew trees, that had
approached an older house, and the hall stood serenely spread out,
winking its Georgian panes as if cheerfully. Behind, there were really
beautiful gardens.
Connie liked the interior much better than Wragby. It was much
lighter, more alive, shapen and elegant. The rooms were panelled
with creamy-painted panelling, the ceilings were touched with gilt,
and everything was kept in exquisite order, all the appointments
were perfect, regardless of expense. Even the corridors managed to
be ample and lovely, softly curved and full of life.
But Leslie Winter was alone. He had adored his house. But his park
was bordered by three of his own collieries. He had been a generous
man in his ideas. He had almost welcomed the colliers in his park.
Had the miners not made him rich! So, when he saw the gangs of
unshapely men lunging by his ornamental waters—not on the private
part of the park, no, he drew the line there—he would say: "the
miners are perhaps not so ornamental as deer, but they are far more
profitable."
But that was in the golden—monetarily—latter half of Queen
Victoria's reign. Miners were then "good working men."
Winter had made this speech, half apologetic, to his guest, the then
Prince of Wales. And the Prince had replied, in his rather guttural
English:
"You are quite right. If there were coal under Sandringham, I would
open a mine on the lawns, and think it first-rate landscape
gardening. Oh, I am quite willing to exchange roe-deer for colliers, at
the price. Your men are good men too, I hear."
But then, the Prince had perhaps an exaggerated idea of the beauty
of money, and the blessings of industrialism.
However, the Prince had been a King, and the King had died, and
now there was another King, whose chief function seemed to be, to
open soup-kitchens.
And the good working men were somehow hemming Shipley in. New
mining villages crowded on the park, and the squire felt somehow
that the population was alien. He used to feel, in a good-natured but
quite grand way, lord of his own domain and of his own colliers. Now,
by a subtle pervasion of the new spirit, he had somehow been
pushed out. It was he who did not belong any more. There was no
mistaking it. The mines, the industry had a will of its own, and this
will was against the gentleman-owner. All the colliers took part in the
will, and it was hard to live up against it. It either shoved you out of
the place, or out of life altogether.
Squire Winter, a soldier, had stood it out. But he no longer cared to
walk in the park after dinner. He almost hid, indoors. Once he had
walked, bare-headed, and in his patent-leather shoes and purple silk
socks, with Connie down to the gate, talking to her in his well-bred
rather haw-haw fashion. But when it came to passing the little gangs
of colliers who stood and stared without either salute or anything
else, Connie felt how the lean, well-bred old man winced, winced as
an elegant antelope stag in a cage winces from the vulgar stare. The
colliers were not personally hostile: not at all. But their spirit was
cold, and shoving him out. And deep down, there was a profound
grudge. They "worked for him." And in their ugliness, they resented
his elegant, well-groomed, well-bred existence. "Who's he!" It was
the difference they resented.
And somewhere, in his secret English heart, being a good deal of a
soldier, he believed they were right to resent the difference. He felt
himself a little in the wrong, for having all the advantages.
Nevertheless he represented a system, and he would not be shoved
out.
Except by death. Which came on him soon after Connie's call,
suddenly. And he remembered Clifford handsomely in his will.
The heirs at once gave out the order for the demolishing of Shipley.
It cost too much to keep up. No one would live there. So it was
broken up. The avenue of yews was cut down. The park was
denuded of its timber, and divided into lots. It was near enough to
Uthwaite. In the strange, bald desert of this still-one-more no-man's-
land, new little streets of semi-detacheds were run up, very
desirable! The Shipley Hall Estate!
Within a year of Connie's last call, it had happened. There stood
Shipley Hall Estate, an array of red-brick semi-detached "villas" in
new streets. No one would have dreamed that the stucco hall had
stood there twelve months before.
But this is a later stage of King Edward's landscape gardening, the
sort that has an ornamental coal mine on the lawn.
One England blots out another. The England of the Squire Winters
and the Wragby Halls was gone, dead. The blotting out was only not
yet complete.
What would come after? Connie could not imagine. She could only
see the new brick streets spreading into the fields, the new erections
rising at the collieries, the new girls in their silk stockings, the new
collier lads lounging into the Pally or the Welfare. The younger
generation were utterly unconscious of the old England. There was a
gap in the continuity of consciousness, almost American: but
industrial really. What next?
Connie always felt there was no next. She wanted to hide her head
in the sand: or at least, in the bosom of a living man.
The world was so complicated and weird and gruesome! The
common people were so many, and really, so terrible. So she
thought as she was going home, and saw the colliers trailing from
the pits, grey-black, distorted, one shoulder higher than the other,
slurring their heavy ironshod boots. Underground grey faces, whites
of eyes rolling, necks cringing from the pit roof, shoulders out of
shape. Men! Men! Alas, in some ways patient and good men. In
other ways, non-existent. Something that men should have was bred
and killed out of them. Yet they were men. They begot children. One
might bear a child to them. Terrible, terrible thought! They were good
and kindly. But they were only half, only the grey half of a human
being. As yet, they were "good." But even that was the goodness of
their halfness. Supposing the dead in them ever rose up! But no, it
was too terrible to think of. Connie was absolutely afraid of the
industrial masses. They seemed so weird to her. A life with utterly no
beauty in it, no intuition, always "in the pit."
Children from such men! Oh God, oh God!
Yet Mellors had come from such a father. Not quite. Forty years had
made a difference, an appalling difference in manhood. The iron and
the coal had eaten deep into the bodies and souls of the men.
Incarnate ugliness, and yet alive! What would become of them all?
Perhaps with the passing of the coal they would disappear again, off
the face of the earth. They had appeared out of nowhere in their
thousands, when the coal had called for them. Perhaps they were
only weird fauna of the coalseams. Creatures of another reality, they
were elementals, serving the elements of coal, as the metal workers
were elementals, serving the element of iron. Men not men, but
animas of coal and iron and clay. Fauna of the elements, carbon,
iron, silicon: elementals. They had perhaps some of the weird
inhuman beauty of minerals, the lustre of coal, the weight and
blueness and resistance of iron, the transparency of glass.
Elemental creatures, weird and distorted, of the mineral world! They
belonged to the coal, the iron, the clay, as fish belong to the sea and
worms to dead wood. The anima of mineral disintegration!
Connie was glad to be home, to bury her head in the sand. She was
glad even to babble to Clifford. For her fear of the mining and iron
Midlands affected her with a queer feeling that went all over her, like
influenza.
"Of course I had to have tea in Miss Bentley's shop," she said.
"Really! Winter would have given you tea."
"Oh yes, but I daren't disappoint Miss Bentley."
Miss Bentley was a sallow old maid with a rather large nose and
romantic disposition, who served tea with a careful intensity worthy
of a sacrament.
"Did she ask after me?" said Clifford.
"Of course!—May I ask your Ladyship how Sir Clifford is!—I believe
she ranks you even higher than Nurse Cavell!"
"And I suppose you said I was blooming."
"Yes! And she looked as rapt as if I had said the heavens had
opened to you. I said if she ever came to Tevershall she was to
come and see you."
"Me! Whatever for! See me!"
"Why yes, Clifford. You can't be so adored without making some
slight return. Saint George of Cappadocia was nothing to you, in her
eyes."
"And do you think she'll come?"
"Oh, she blushed! and looked quite beautiful for a moment, poor
thing! Why don't men marry the women who would really adore
them?"
"The women start adoring too late. But did she say she'd come?"
"Oh!" Connie imitated the breathless Miss Bentley, "your Ladyship, if
ever I should dare to presume!"
"Dare to presume! how absurd! But I hope to God she won't turn up.
And how was her tea?"
"Oh, Lipton's and very strong! But Clifford, do you realise you are the
Roman de la rose of Miss Bentley and lots like her?"
"I'm not flattered, even then."
"They treasure up every one of your pictures in the illustrated
papers, and probably pray for you every night. It's rather wonderful."
She went upstairs to change.
That evening he said to her:
"You do think, don't you, that there is something eternal in
marriage?"
She looked at him.
"But Clifford, you make eternity sound like a lid or a long, long chain
that trailed after one, no matter how far one went."
He looked at her, annoyed.
"What I mean," he said, "is that if you go to Venice, you won't go in
the hopes of some love affair that you can take au grand sérieux, will
you?"
"A love affair in Venice au grand sérieux? No, I assure you! No, I'd
never take a love affair in Venice more than au très petit sérieux."
She spoke with a queer kind of contempt. He knitted his brows,
looking at her.
Coming downstairs in the morning, she found the keeper's dog
Flossie sitting in the corridor outside Clifford's room, and whimpering
very faintly.
"Why Flossie!" she said softly, "What are you doing here?"
And she quietly opened Clifford's door. Clifford was sitting up in bed,
with the bed-table and typewriter pushed aside, and the keeper was
standing attention at the foot of the bed. Flossie ran in. With a faint
gesture of head and eyes, Mellors ordered her to the door again, and
she slunk out.
"Oh, good morning Clifford!" Connie said. "I didn't know you were
busy." Then she looked at the keeper, saying good morning to him.
He murmured his reply, looking at her as if vaguely. But she felt a
whiff of passion touch her, from his mere presence.
"Did I interrupt you, Clifford? I'm sorry."
"No, it's nothing of any importance."
She slipped out of the room again, and up to the blue boudoir on the
first floor. She sat in the window, and saw him go down the drive,
with his curious, silent motion, effaced. He had a natural sort of quiet
distinction, an aloof pride, and also a certain look of frailty. A hireling!
One of Clifford's hirelings! "The fault, dear Brutus, is not in our stars,
but in ourselves, that we are underlings."
Was he an underling? Was he? What did he think of her?
It was a sunny day, and Connie was working in the garden, and Mrs.
Bolton was helping her. For some reason, the two women had drawn
together, in one of the unaccountable flows and ebbs of sympathy
that exist between people. They were pegging down carnations, and
putting in small plants for the summer. It was work they both liked.
Connie especially felt a delight in putting the soft roots of young
plants into a soft black puddle, and cradling them down. On this
spring morning she felt a quiver in her womb too, as if the sunshine
had touched it and made it happy.
"It is many years since you lost your husband?" she said to Mrs.
Bolton, as she took up another little plant and laid it in its hole.
"Twenty-three!" said Mrs. Bolton, as she carefully separated the
young columbines into single plants. "Twenty-three years since they
brought him home."
Connie's heart gave a lurch, at the terrible finality of it. "Brought him
home!"
"Why did he get killed, do you think?" she asked. "He was happy
with you?"
It was a woman's question to a woman. Mrs. Bolton put aside a
strand of hair from her face, with the back of her hand.
"I don't know, my Lady! He sort of wouldn't give in to things: he
wouldn't really go with the rest. And then he hated ducking his head
for anything on earth. A sort of obstinacy, that gets itself killed. You
see he didn't really care. I lay it down to the pit. He ought never to
have been down pit. But his dad made him go down, as a lad; and
then, when you're over twenty, it's not very easy to come out."
"Did he say he hated it?"
"Oh no! Never! He never said he hated anything. He just made a
funny face. He was one of those who wouldn't take care: like some
of the first lads as went off so blithe to the war and got killed right
away. He wasn't really wezzle-brained. But he wouldn't care. I used
to say to him: 'You care for nought nor nobody!' But he did! The way
he sat when my first baby was born, motionless, and the sort of fatal
eyes he looked at me with, when it was over! I had a bad time, but I
had to comfort him. 'It's all right, lad, it's all right!' I said to him. And
he gave me a look, and that funny sort of smile. He never said
anything. But I don't believe he had any right pleasure with me at
nights after; he'd never really let himself go. I used to say to him:
'Oh, let thysen go, lad!'—I'd talk broad to him sometimes. And he
said nothing. But he wouldn't let himself go, or he couldn't. He didn't
want me to have any more children. I always blamed his mother, for
letting him in th' room. He'd no right t'ave been there. Men makes so
much more of things than they should, once they start brooding."
"Did he mind so much?" said Connie in wonder.
"Yes, he sort of couldn't take it for natural, all that pain. And it spoilt
his pleasure in his bit of married love. I said to him: If I don't care,
why should you? It's my look-out!—But all he'd ever say was: It's not
right!"
"Perhaps he was too sensitive," said Connie.
"That's it! When you come to know men, that's how they are: too
sensitive in the wrong place. And I believe, unbeknown to himself, he
hated the pit, just hated it. He looked so quiet when he was dead, as
if he'd got free. He was such a nice looking lad. It just broke my heart
to see him, so still and pure looking, as if he'd wanted to die. Oh, it
broke my heart, that did. But it was the pit."
She wept a few bitter tears, and Connie wept more. It was a warm
spring day, with a perfume of earth and of yellow flowers, many
things rising to bud, and the garden still with the very sap of
sunshine.
"It must have been terrible for you!" said Connie.
"Oh, my Lady! I never realised at first. I could only say: Oh my lad,
what did you want to leave me for!—That was all my cry. But
somehow I felt he'd come back."
"But he didn't want to leave you," said Connie.
"Oh, no, my Lady! That was only my silly cry. And I kept expecting
him back. Especially at nights. I kept waking up thinking: Why he's
not in bed with me!—It was as if my feelings wouldn't believe he'd
gone. I just felt he'd have to come back and lie against me, so I
could feel him with me. That was all I wanted, to feel him there with
me, warm. And it took me a thousand shocks before I knew he
wouldn't come back, it took me years."
"The touch of him," said Connie.
"That's it, my Lady! the touch of him! I've never got over it to this day,
and never shall. And if there's a heaven above, he'll be there, and
will lie up against me so I can sleep."
Connie glanced at the handsome, brooding face in fear. Another
passionate one out of Tevershall! The touch of him! For the bonds of
love are ill to loose!
"It's terrible, once you've got a man into your blood!" she said.
"Oh, my Lady! And that's what makes you feel so bitter. You feel
folks wanted him killed. You feel the pit fair wanted to kill him. Oh, I
felt, if it hadn't been for the pit, an' them as runs the pit, there'd have
been no leaving me. But they all want to separate a woman and a
man, if they're together."
"If they're physically together," said Connie.
"That's right my Lady! There's a lot of hard-hearted folks in the world.
And every morning when he got up and went to th' pit, I felt it was
wrong, wrong. But what else could he do? What can a man do?"
A queer hate flared in the woman.
"But can a touch last so long?" Connie asked suddenly. "That you
could feel him so long?"
"Oh my Lady, what else is there to last? Children grows away from
you. But the man, well—! But even that they'd like to kill in you, the
very thought of the touch of him. Even your own children! Ah well!
We might have drifted apart, who knows. But the feeling's something
different. It's 'appen better never to care. But there, when I look at
women who's never really been warmed through by a man, well,
they seem to me poor dool-owls after all, no matter how they may
dress up and gad. No, I'll abide by my own. I've not much respect for
people."
CHAPTER XII
Connie went to the wood directly after lunch. It was really a lovely
day, the first dandelions making suns, the first daisies so white. The
hazel thicket was a lacework of half-open leaves, and the last dusty
perpendicular of the catkins. Yellow celandines now were in crowds,
flat open, pressed back in urgency, and the yellow glitter of
themselves. It was the yellow, the powerful yellow of early summer.
And primroses were broad, and full of pale abandon, thick-clustered
primroses no longer shy. The lush, dark green of hyacinths was a
sea, with buds rising like pale corn, while in the riding the forget-me-
nots were fluffing up, and columbines were unfolding their ink-purple
riches, and there were bits of bluebird's eggshell under a bush.
Everywhere the bud-knots and the leap of life!
The keeper was not at the hut. Everything was serene, brown
chickens running lustily. Connie walked on towards the cottage,
because she wanted to find him.
The cottage stood in the sun, off the wood's edge. In the little garden
the double daffodils rose in tufts, near the wide-open door, and red
double daisies made a border to the path. There was the bark of a
dog, and Flossie came running.
The wide-open door! so he was at home. And the sunlight falling on
the red-brick floor! As she went up the path, she saw him through the
window, sitting at the table in his shirtsleeves, eating. The dog
wuffed softly, slowly wagging her tail.
He rose, and came to the door, wiping his mouth with a red
handkerchief, still chewing.
"May I come in?" she said.
"Come in!"
The sun shone into the bare room, which still smelled of a mutton
chop, done in a dutch oven before the fire, because the dutch oven
still stood on the fender, with the black potato-saucepan on a piece
of paper beside it on the white hearth. The fire was red, rather low,
the bar dropped, the kettle singing.
On the table was his plate, with potatoes and the remains of the
chop; also bread in a basket, salt, and a blue mug with beer. The
tablecloth was white oil-cloth. He stood in the shade.
"You are very late," she said. "Do go on eating!"
She sat down on a wooden chair, in the sunlight by the door.
"I had to go to Uthwaite," he said, sitting down at table but not eating.
"Do eat," she said.
But he did not touch the food.
"Shall y'ave something?" he asked her. "Shall y'ave a cup of tea? t'
kettle's on t' boil." He half rose again from his chair.
"If you'll let me make it myself," she said rising. He seemed sad, and
she felt she was bothering him.
"Well, teapot's in there,"—he pointed to a little, drab corner
cupboard; "an' cups. An' tea's on t' mantel ower yer 'ead."
She got the black teapot, and the tin of tea from the mantelshelf. She
rinsed the teapot with hot water, and stood a moment wondering
where to empty it.
"Thrown it out," he said, aware of her. "It's clean."
She went to the door and threw the drop of water down the path.
How lovely it was here, so still, so really woodland. The oaks were
putting out ochre yellow leaves; in the garden the red daisies were
like red plush buttons. She glanced at the big, hollow sandstone slab
of the threshold, now crossed by so few feet.
"But it's lovely here," she said. "Such a beautiful stillness, everything
alive and still."
He was eating again, rather slowly and unwillingly, and she could
feel he was discouraged. She made the tea in silence, and set the
teapot on the hob, as she knew the people did. He pushed his plate
aside and went to the back place; she heard a latch click, then he
came back with cheese on a plate, and butter.
She set the two cups on the table, there were only two.
"Will you have a cup of tea?" she said.
"If you like. Sugar's in th' cupboard, an' there's a little cream-jug.
Milk's in a jug in th' pantry."
"Shall I take your plate away?" she asked him. He looked up at her
with a faint ironical smile.
"Why ... if you like," he said, slowly eating bread and cheese. She
went to the back, into the penthouse scullery, where the pump was.
On the left was a door, no doubt the pantry door. She unlatched it,
and almost smiled at the place he called a pantry; a long narrow
whitewashed slip of a cupboard. But it managed to contain a little
barrel of beer, as well as a few dishes and bits of food. She took a
little milk from the yellow jug.
"How do you get your milk?" she asked him, when she came back to
the table.
"Flints! They leave me a bottle at the warren end. You know, where I
met you!"
But he was discouraged.
She poured out the tea, poising the cream-jug.
"No milk," he said; then he seemed to hear a noise, and looked
keenly through the doorway.
"'Appen we'd better shut," he said.
"It seems a pity," she replied. "Nobody will come, will they?"
"No unless it's one in a thousand, but you never know."
"And even then it's no matter," she said. "It's only a cup of tea.
Where are the spoons?"
He reached over, and pulled open the table drawer. Connie sat at
table in the sunshine of the doorway.
"Flossie!" he said to the dog, who was lying on a little mat at the stair
foot. "Go an' hark, hark!"
He lifted his finger, and his "hark!" was very vivid. The dog trotted out
to reconnoitre.
"Are you sad today?" she asked him.
He turned his blue eyes quickly, and gazed direct on her.
"Sad! no, bored! I had to go getting summonses for two poachers I
caught, and oh well, I don't like people."
He spoke cold, good English, and there was anger in his voice.
"Do you hate being a gamekeeper?" she asked.
"Being a gamekeeper, no! So long as I'm left alone. But when I have
to go messing around at the police station, and various other places,
and waiting for a lot of fools to attend to me ... oh well, I get mad ..."
and he smiled, with a certain faint humour.
"Couldn't you be really independent?" she asked.
"Me? I suppose I could, if you mean manage to exist on my pension.
I could! But I've got to work, or I should die. That is, I've got to have
something that keeps me occupied. And I'm not in a good enough
temper to work for myself. It's got to be a sort of job for somebody
else, or I should throw it up in a month, out of bad temper. So
altogether I'm very well off here, especially lately...."
He laughed at her again, with mocking humour.
"But why are you in a bad temper?" she asked. "Do you mean you
are always in a bad temper?"
"Pretty well," he said, laughing. "I don't quite digest my bile."
"But what bile?" she said.
"Bile!" he said. "Don't you know what that is?" She was silent, and
disappointed. He was taking no notice of her.
"I'm going away for a while next month," she said.
"You are! Where to?"
"Venice."
"Venice! With Sir Clifford? For how long?"
"For a month or so," she replied. "Clifford won't go."
"He'll stay here?" he asked.
"Yes! He hates to travel as he is."
"Ay, poor devil!" he said, with sympathy.
There was a pause.
"You won't forget me when I'm gone, will you?" she asked. Again he
lifted his eyes and looked full at her.
"Forget?" he said. "You know nobody forgets. It's not a question of
memory."
She wanted to say: "What then?" but she didn't. Instead, she said in
a mute kind of voice: "I told Clifford I might have a child."
Now he really looked at her, intense and searching.
"You did?" he said at last. "And what did he say?"
"Oh, he wouldn't mind. He'd be glad, really, so long as it seemed to
be his." She dared not look up at him.
He was silent a long time, then he gazed again on her face.
"No mention of me, of course?" he said.
"No. No mention of you," she said.
"No, he'd hardly swallow me as a substitute breeder.—Then where
are you supposed to be getting the child?"
"I might have a love affair in Venice," she said.
"You might," he replied slowly. "So that's why you're going?"
"Not to have the love affair," she said, looking up at him, pleading.
"Just the appearance of one," he said.
There was silence. He sat staring out of the window, with a faint grin,
half mockery, half bitterness, on his face. She hated his grin.
"You've not taken any precautions against having a child then?" he
asked her suddenly. "Because I haven't."
"No," she said faintly. "I should hate that."
He looked at her, then again with the peculiar subtle grin out of the
window. There was a tense silence.
At last he turned to her and said satirically:
"That was why you wanted me then, to get a child?"
She hung her head.
"No. Not really," she said.
"What then, really?" he asked rather bitingly.
She looked up at him reproachfully, saying: "I don't know." He broke
into a laugh.
"Then I'm damned if I do," he said.
There was a long pause of silence, a cold silence.
"Well," he said at last. "It's as your Ladyship likes. If you get the
baby, Sir Clifford's welcome to it. I shan't have lost anything. On the
contrary, I've had a very nice experience, very nice indeed!" and he
stretched in a half suppressed sort of yawn. "If you've made use of
me," he said, "it's not the first time I've been made use of; and I don't
suppose it's ever been as pleasant as this time; though of course
one can't feel tremendously dignified about it." He stretched again,
curiously, his muscles quivering, and his jaw oddly set.
"But I didn't make use of you," she said, pleading.
"At your Ladyship's service," he replied.
"No," she said. "I liked your body."
"Did you?" he replied, and he laughed. "Well then, we're quits,
because I liked yours."
He looked at her with queer darkened eyes.
"Would you like to go upstairs now?" he asked her, in a strangled
sort of voice.
"No, not here. Not now!" she said heavily, though if he had used any
power over her, she would have gone, for she had no strength
against him.
He turned his face away again, and seemed to forget her.
"I want to touch you like you touch me," she said. "I've never really
touched your body."
He looked at her, and smiled again. "Now?" he said.
"No! No! Not here! At the hut. Would you mind?"
"How do I touch you?" he asked.
"When you feel me."
He looked at her, and met her heavy, anxious eyes.
"And do you like it when I feel you?" he asked, laughing at her still.
"Yes, do you?" she said.
"Oh, me!" Then he changed his tone. "Yes," he said. "You know
without asking." Which was true.
She rose and picked up her hat. "I must go," she said.
"Will you go?" he replied politely.
She wanted him to touch her, to say something to her, but he said
nothing, only waited politely.
"Thank you for the tea," she said.
"I haven't thanked your Ladyship for doing me the honours of my
teapot," he said.
She went down the path, and he stood in the doorway, faintly
grinning. Flossie came running with her tail lifted. And Connie had to
plod dumbly across into the wood, knowing he was standing there
watching her, with that incomprehensible grin on his face.
She walked home very much downcast and annoyed. She didn't at
all like his saying he had been made use of; because in a sense it
was true. But he oughtn't to have said it. Therefore, again, she was
divided between two feelings; resentment against him, and a desire
to make it up with him.
She passed a very uneasy and irritated teatime, and at once went up
to her room. But when she was there it was no good; she could
neither sit nor stand. She would have to do something about it. She
would have to go back to the hut; if he was not there, well and good.
She slipped out of the side door, and took her way direct and a little
sullen. When she came to the clearing she was terribly uneasy. But
there he was again, in his shirtsleeves, stooping, letting the hens out
of the coops, among the chicks that were now growing a little gawky,
but were much more trim than hen-chickens.
She went straight across to him.
"You see I've come!" she said.
"Ay, I see it!" he said, straightening his back, and looking at her with
a faint amusement.
"Do you let the hens out now?" she asked.
"Yes, they've sat themselves to skin and bone," he said. "An' now
they're not all that anxious to come out an' feed. There's no self in a
sitting hen; she's all in the eggs or the chicks."
The poor mother hens; such blind devotion! even to eggs not their
own! Connie looked at them in compassion. A helpless silence fell
between the man and the woman.
"Shall us go i' th' 'ut?" he asked.
"Do you want me?" she asked, in a sort of mistrust.
"Ay, if you want to come."
She was silent.
"Come then!" he said.
And she went with him to the hut. It was quite dark when he had shut
the door, so he made a small light in the lantern, as before.
"Have you left your underthings off?" he asked her.
"Yes!"
"Ay, well, then I'll take my things off too."
He spread the blankets, putting one at the side for a coverlet. She
took off her hat, and shook her hair. He sat down, taking off his
shoes and gaiters, and undoing his cord breeches.
"Lie down then!" he said, when he stood in his shirt. She obeyed in
silence, and he lay beside her, and pulled the blanket over them
both.
"There!" he said.
And he lifted her dress right back, till he came even to her breasts.
He kissed them softly, taking the nipples in his lips in tiny caresses.
"Eh, but tha'rt nice, tha'rt nice!" he said, suddenly rubbing his face
with a snuggling movement against her warm belly.
And she put her arms round him under his shirt, but she was afraid,
afraid of his thin, smooth, naked body, that seemed so powerful,
afraid of the violent muscles. She shrank, afraid.
And when he said, with a sort of little sigh: "Eh, tha'rt nice!"
something in her quivered, and something in her spirit stiffened in
resistance: stiffened from the terribly physical intimacy, and from the
peculiar haste of his possession. And this time the sharp ecstacy of
her own passion did not overcome her; she lay with her hands inert
on his striving body, and do what she might, her spirit seemed to
look on from the top of her head, and the butting of his haunches
seemed ridiculous to her, and the sort of anxiety of his penis to come
to its little evacuating crisis seemed farcical. Yes, this was love, this
ridiculous bouncing of the buttocks, and the wilting of the poor
insignificant, moist little penis. This was the divine love! After all, the
moderns were right when they felt contempt for the performance; for
it was a performance. It was quite true, as some poets said, that the
God who created man must have had a sinister sense of humour,
creating him a reasonable being, yet forcing him to take this
ridiculous posture, and driving him with blind craving for this
ridiculous performance. Even a Maupassant found it a humiliating
anticlimax. Men despised the intercourse act, and yet did it.
Cold and derisive her queer female mind stood apart, and though
she lay perfectly still, her impulse was to heave her loins, and throw
the man out, escape his ugly grip, and the butting overriding of his
absurd haunches. His body was a foolish, impudent, imperfect thing,
a little disgusting in its unfinished clumsiness. For surely a complete
evolution would eliminate this performance, this "function."
And yet when he had finished, soon over, and lay very very still,
receding into silence, and a strange, motionless distance, far, farther
than the horizon of her awareness, her heart began to weep. She
could feel him ebbing away, ebbing away, leaving her there like a
stone on a shore. He was withdrawing, his spirit was leaving her. He
knew.
And in real grief, tormented by her own double consciousness and
reaction, she began to weep. He took no notice, or did not even
know. The storm of weeping swelled and shook her, and shook him.
"Ay!" he said, "It was no good that time. You wasn't there." So he
knew! Her sobs became violent.
"But what's amiss?" he said. "It's once in a while that way."
"I ... I can't love you," she sobbed, suddenly feeling her heart
breaking.
"Canna ter? Well, dunna fret! There's no law says as tha's got to.
Ta'e it for what it is."
He still lay with his hand on her breast. But she had drawn both her
hands from him.
His words were small comfort. She sobbed aloud.
"Nay, nay," he said. "Ta'e the thick wi' th' thin. This wor' a bit o' thin
for once."
She wept bitterly, sobbing: "But I want to love you, and I can't. It only
seems horrid."
He laughed a little, half bitter, half amused.
"It isna horrid," he said, "even if tha thinks it is. An' tha canna ma'e it
horrid. Dunna fret thysen about lovin' me. Tha'lt niver force thysen to
't. There's sure to be a bad nut in a basketful. Tha mun ta'e th' rough
wi' th' smooth."
He took his hand away from her breast, not touching her. And now
she was untouched she took an almost perverse satisfaction in it.
She hated the dialect: the thee and the tha and the thysen. He could
get up if he liked, and stand there above her buttoning down those
absurd corduroy breeches, straight in front of her. After all, Michaelis
had had the decency to turn away. This man was so assured in
himself, he didn't know what a clown other people found him, a half-
bred fellow.
Yet, as he was drawing away, to rise silently and leave her, she clung
to him in terror.
"Don't! Don't go! Don't leave me! Don't be cross with me! Hold me!
Hold me fast!" she whispered in blind frenzy, not even knowing what
she said, and clinging to him with uncanny force. It was from herself
she wanted to be saved, from her own inward anger and resistance.
Yet how powerful was that inward resistance that possessed her!
He took her in his arms again and drew her to him, and suddenly she
became small in his arms, small and nestling. It was gone, the
resistance was gone, and she began to melt in a marvellous peace.
And as she melted small and wonderful in his arms, she became
infinitely desirable to him, all his blood-vessels seemed to scald with
intense yet tender desire, for her, for her softness, for the penetrating
beauty of her in his arms, passing into his blood. And softly, with that
marvellous swoon-like caress of his hand in pure soft desire, softly
he stroked the silky slope of her loins, down, down between her soft
warm buttocks, coming nearer and nearer to the very quick of her.
And she felt him like a flame of desire, yet tender, and she felt
herself melting in the flame. She let herself go. She felt his penis
risen against her with silent amazing force and assertion, and she let
herself go to him. She yielded with a quiver that was like death, she
went all open to him. And oh, if he were not tender to her now, how
cruel, for she was all open to him and helpless!
She quivered again at the potent inexorable entry inside her, so
strange and terrible. It might come with the thrust of a sword in her